Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC. 2002

Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea.

Caffeine is one of the most widely consumed neuroactive drugs, coming mostly from everyday beverages such as coffee and tea. To investigate whether caffeine induces apoptosis in the central nervous system, 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, 4,6-diamidino-2-phenylindole (DAPI) staining, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) assay, flow cytometric analysis, DNA fragmentation assay, and caspase-3 enzyme assay were performed on SK-N-MC human neuroblastoma cells. Cells treated with caffeine at concentrations as high as 10 mM exhibited several characteristics of apoptosis. In addition, caffeine was shown to increase the caspase-3 activity. These results suggest that high-dose of caffeine induces apoptosis in human neuroblastoma cells, probably by increasing the caspase-3 enzyme activity.

UI MeSH Term Description Entries
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D053148 Caspase 3 A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA. CASP3,Apopain,Caspase-3,Pro-Caspase-3,Procaspase-3,Pro Caspase 3,Procaspase 3
D053938 DNA Fragmentation Splitting the DNA into shorter pieces by endonucleolytic DNA CLEAVAGE at multiple sites. It includes the internucleosomal DNA fragmentation, which along with chromatin condensation, are considered to be the hallmarks of APOPTOSIS. DNA Degradation, Apoptotic,Apoptotic DNA Degradation,Fragmentation, DNA

Related Publications

Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
October 2003, Journal of chemical neuroanatomy,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
March 2001, Journal of neurochemistry,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
January 2018, International journal of biological sciences,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
January 2006, Journal of neurochemistry,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
November 1998, FEBS letters,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
April 2002, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
September 2000, European journal of biochemistry,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
June 2005, Neurotoxicology,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
November 2002, Zhonghua yi xue za zhi,
Mi-Hyeon Jang, and Min-Chul Shin, and In-Sug Kang, and Hyung-Hwan Baik, and Yong-Ho Cho, and Jong-Phill Chu, and Ee-Hwa Kim, and Chang-Ju Kim
July 1981, In vitro,
Copied contents to your clipboard!